Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios Anagnostopoulos

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Journal of the Endocrine Society|December 22, 2017
Proteomics of Children Born After Intracytoplasmic Sperm Injection Reveal Indices of an Adverse Cardiometabolic ProfileIoanna Kosteria, George Th Tsangaris, Alexandra Gkourogianni, et al.
Leukemia & Lymphoma|September 13, 2006
Macrofocal multiple myeloma in young patients: a distinct entity with favorable prognosisMeletios Athanasios Dimopoulos, Anastasia Pouli, Athanasios Anagnostopoulos, et al.
Clinical Lymphoma & Myeloma|January 19, 2007
Prognostic value of serum beta2-microglobulin in patients with Waldenstrom's macroglobulinemia requiring treatmentAthanasios Anagnostopoulos, Konstantinos Zervas, Marie Kyrtsonis, et al.
Haematologica|June 8, 2006
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acidMeletios A Dimopoulos, Efstathios Kastritis, Athanasios Anagnostopoulos, et al.
Leukemia & Lymphoma|May 27, 2004
High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myelomaMichele L Donato, Ana Aleman, Richard E Champlin, et al.
American Journal of Clinical Oncology|April 9, 2013
Postoperative treatment with docetaxel, cisplatin, and capecitabine (DCX) and chemoradiotherapy (CRT) with capecitabine for resected gastric adenocarcinomaZacharenia Saridaki, Georgia Lambrodimou, Stefanos Kachris, et al.
Haematologica|November 21, 2007
Melphalan-induced DNA damage in vitro as a predictor for clinical outcome in multiple myelomaMeletios A Dimopoulos, Vassilis L Souliotis, Athanasios Anagnostopoulos, et al.
European Journal of Haematology|September 30, 2005
Multiple myeloma in elderly patients: prognostic factors and outcomeAthanasios Anagnostopoulos, Dimitra Gika, Argyris Symeonidis, et al.
Nanomaterials (Basel, Switzerland)|November 24, 2023
CNT-PUFs: Highly Robust and Heat-Tolerant Carbon-Nanotube-Based Physical Unclonable FunctionsFlorian Frank, Simon Böttger, Nico Mexis, et al.
Anti-Cancer Drugs|December 17, 2009
Myelotoxicity of oral topotecan in relation to treatment duration and dosage: a phase I studyGeorge P Stathopoulos, Alexandros Ardavanis, Pavlos Papakotoulas, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Journal of the Endocrine Society|December 22, 2017
Proteomics of Children Born After Intracytoplasmic Sperm Injection Reveal Indices of an Adverse Cardiometabolic ProfileIoanna Kosteria, George Th Tsangaris, Alexandra Gkourogianni, et al.
Leukemia & Lymphoma|September 13, 2006
Macrofocal multiple myeloma in young patients: a distinct entity with favorable prognosisMeletios Athanasios Dimopoulos, Anastasia Pouli, Athanasios Anagnostopoulos, et al.
Clinical Lymphoma & Myeloma|January 19, 2007
Prognostic value of serum beta2-microglobulin in patients with Waldenstrom's macroglobulinemia requiring treatmentAthanasios Anagnostopoulos, Konstantinos Zervas, Marie Kyrtsonis, et al.
Haematologica|June 8, 2006
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acidMeletios A Dimopoulos, Efstathios Kastritis, Athanasios Anagnostopoulos, et al.
Leukemia & Lymphoma|May 27, 2004
High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myelomaMichele L Donato, Ana Aleman, Richard E Champlin, et al.
American Journal of Clinical Oncology|April 9, 2013
Postoperative treatment with docetaxel, cisplatin, and capecitabine (DCX) and chemoradiotherapy (CRT) with capecitabine for resected gastric adenocarcinomaZacharenia Saridaki, Georgia Lambrodimou, Stefanos Kachris, et al.
Haematologica|November 21, 2007
Melphalan-induced DNA damage in vitro as a predictor for clinical outcome in multiple myelomaMeletios A Dimopoulos, Vassilis L Souliotis, Athanasios Anagnostopoulos, et al.
European Journal of Haematology|September 30, 2005
Multiple myeloma in elderly patients: prognostic factors and outcomeAthanasios Anagnostopoulos, Dimitra Gika, Argyris Symeonidis, et al.
Nanomaterials (Basel, Switzerland)|November 24, 2023
CNT-PUFs: Highly Robust and Heat-Tolerant Carbon-Nanotube-Based Physical Unclonable FunctionsFlorian Frank, Simon Böttger, Nico Mexis, et al.
Anti-Cancer Drugs|December 17, 2009
Myelotoxicity of oral topotecan in relation to treatment duration and dosage: a phase I studyGeorge P Stathopoulos, Alexandros Ardavanis, Pavlos Papakotoulas, et al.
Pageof 6